Physician profile
Li Tao
NPI 1063832483
$1,213.66
in general payments reported to CMS, 2019-2025
18 companies · $58.27 in 2025
The $58.27 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $101 · 2021: $214 · 2022: $271 · 2023: $206 · 2024: $130 · 2025: $58.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $302.28 | 2019-2024 | Xarelto |
| Ucb, INC. | $140.88 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $126.21 | 2021-2023 | |
| Astellas Pharma US INC | $112.02 | 2023-2025 | Cresemba |
| Merck Sharp & Dohme LLC | $111.98 | 2019-2025 | Zerbaxa |
| Astrazeneca Pharmaceuticals LP | $101.28 | 2020-2024 | Andexxa |
| Pfizer INC. | $73.21 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $54.89 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.42 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $21.79 | 2024 | Opsumit |
| Abbott Laboratories | $21.07 | 2019 | |
| Vyera Pharmaceuticals, LLC | $21.07 | 2019 | |
| Nabriva Therapeutics, Plc | $20.62 | 2020 | |
| Boston Scientific Corporation | $19.64 | 2019 | |
| Smith+Nephew, INC. | $14.56 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $13.17 | 2023 | |
| Xeris Pharmaceuticals, INC. | $12.24 | 2022 | |
| Paratek Pharmaceuticals, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Li Tao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.